Baxter
BAX
#996
Rank
ยฃ14.96 B
Marketcap
ยฃ29.33
Share price
-0.70%
Change (1 day)
-6.21%
Change (1 year)

Baxter International is a US company operating worldwide in the pharmaceutical and medical technology sectors. The company produces drugs for anesthesiology and intensive care medicine, vaccines and medical devices.

Baxter (BAX) - Total debt

Total debt on the balance sheet as of June 2024 : ยฃ10.16 B

According to Baxter's latest financial reports the company's total debt is ยฃ10.16 B. A companyโ€™s total debt is the sum of all current and non-current debts.

Baxter - Total debt on balance sheet (from 1996 to 2024)

Total debt by year

Year Total debt Change
2023-12-31ยฃ11.27 B-20.71%
2022-12-31ยฃ14.21 B5.1%
2021-12-31ยฃ13.52 B171.45%
2020-12-31ยฃ4.98 B10.96%
2019-12-31ยฃ4.49 B64.46%
2018-12-31ยฃ2.73 B5.11%
2017-12-31ยฃ2.59 B15.26%
2016-12-31ยฃ2.25 B-48.6%
2015-12-31ยฃ4.38 B-24.37%
2014-12-31ยฃ5.80 B4.5%
2013-12-31ยฃ5.55 B51.35%
2012-12-31ยฃ3.66 B9.72%
2011-12-31ยฃ3.34 B17.22%
2010-12-31ยฃ2.85 B10.27%
2009-12-31ยฃ2.58 B-0.73%
2008-12-31ยฃ2.60 B68.38%
2007-12-31ยฃ1.54 B8.19%
2006-12-31ยฃ1.42 B-26.12%
2005-12-31ยฃ1.93 B-13.53%
2004-12-31ยฃ2.23 B-13.2%
2003-12-31ยฃ2.57 B-11.01%
2002-12-31ยฃ2.89 B56.39%
2001-12-31ยฃ1.85 B17.2%
2000-12-31ยฃ1.58 B-10.54%
1999-12-31ยฃ1.76 B-12.71%
1998-12-31ยฃ2.02 B19.69%
1997-12-31ยฃ1.69 B41.93%
1996-12-31ยฃ1.19 B

Total debt for similar companies or competitors

Company Total debt differencediff. Country
ยฃ3.87 B-61.84%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ9.31 B-8.40%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ8.33 B-18.04%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ14.72 B 44.82%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ1.14 B-88.74%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ26.97 B 165.35%๐Ÿ‡บ๐Ÿ‡ธ USA
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ1.81 B-82.16%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ21.23 B 108.84%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
ยฃ1.27 B-87.42%๐Ÿ‡บ๐Ÿ‡ธ USA